0
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Lymphoproliferation, Autoimmunity, and Recurrent Infections: Which Primary Immunodeficiency?

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Related collections

          Most cited references8

          • Record: found
          • Abstract: not found
          • Article: not found

          The 2022 Update of IUIS Phenotypical Classification for Human Inborn Errors of Immunity

            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            22q11 deletion syndrome: current perspective

            Chromosome 22q11 is characterized by the presence of chromosome-specific low-copy repeats or segmental duplications. This region of the chromosome is very unstable and susceptible to mutations. The misalignment of low-copy repeats during nonallelic homologous recombination leads to the deletion of the 22q11.2 region, which results in 22q11 deletion syndrome (22q11DS). The 22q11.2 deletion is associated with a wide variety of phenotypes. The term 22q11DS is an umbrella term that is used to encompass all 22q11.2 deletion-associated phenotypes. The haploinsufficiency of genes located at 22q11.2 affects the early morphogenesis of the pharyngeal arches, heart, skeleton, and brain. TBX1 is the most important gene for 22q11DS. This syndrome can ultimately affect many organs or systems; therefore, it has a very wide phenotypic spectrum. An increasing amount of information is available related to the pathogenesis, clinical phenotypes, and management of this syndrome in recent years. This review summarizes the current clinical and genetic status related to 22q11DS.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              Immunodeficiencies: non-infectious manifestations

              Objectives Classical immunodeficiencies are mainly characterized by infectious conditions. In recent years, manifestations related to allergy, inflammation, autoimmunity, lymphoproliferation, and malignancies related to this group of diseases have been described. The text intends to make an update on the non-infectious manifestations of the primary defects of the immune system. Source of data Searches were carried out in the PubMed database for review articles published in the last five years, in English, French, or Spanish, using the terms “allergy,” “inflammation,” “autoimmunity,” “lymphoproliferation,” “cancer,” AND “immunodeficiency” or “primary immunodeficiency” or “inborn errors of immunity” NOT “HIV”. Synthesis of data Non-infectious manifestations characterize the primary defects in which there is dysregulation of the immune system. The most common manifestations of autoimmunity in this group of diseases are autoimmune cytopenias. Exacerbated inflammatory processes, benign lymphoproliferation, and propensity to malignancy of the lymphoreticular system are related to several diseases in this group. Severe manifestations of atopy or food allergy characterize some immunodeficiencies. Disorders of inborn immunity of the autoinflammatory type are characterized by an aseptic inflammatory process in the absence of autoimmunity, with fever and recurrent manifestations in different organs. Conclusions Not only infectious conditions should raise the suspicion of immunodeficiencies, but also manifestations of allergy, inflammation, autoimmunity, lymphoproliferation, or cancer, especially if they are recurrent, associated to each other, affecting young patients, or in severe and/or difficult to treat conditions.
                Bookmark

                Author and article information

                Journal
                Turk Arch Pediatr
                Turk Arch Pediatr
                Turkish Archives of Pediatrics
                Turkish Pediatrics Association
                2757-6256
                January 2024
                01 January 2024
                : 59
                : 1
                : 106-108
                Affiliations
                [1 ]Department of Pediatric Immunology and Allergy , Ankara University Faculty of Medicine, Ankara, Turkey
                [2 ]Department of Pediatric Health and Diseases , Ankara University Faculty of Medicine, Ankara, Turkey
                [3 ]Medical Park Bahçeşehir Hospital , Clinic of Hematology and Transplantation, İstanbul, Turkey
                [4 ]Intergen Genetics Laboratory , Ankara, Turkey
                Author notes
                Corresponding author:Gökcan Öztürk ✉ gokcan_ozturk@ 123456hotmail.com

                Cite this article as: Öztürk G, Haskoloğlu Ş, Deveci N, et al. Lymphoproliferation, autoimmunity and recurrent infections: Which primary immunodeficiency? Turk Arch Pediatr. 2024; 59(1): 106-108.

                Author information
                http://orcid.org/0000-0001-8958-7968
                http://orcid.org/0000-0002-2668-0441
                http://orcid.org/0000-0002-3390-7798
                http://orcid.org/0009-0004-4911-4815
                http://orcid.org/0000-0002-7750-1781
                http://orcid.org/0000-0002-7707-0029
                http://orcid.org/0000-0003-2786-1911
                http://orcid.org/0000-0003-1145-0843
                http://orcid.org/0000-0002-7869-4941
                Article
                tap-59-1-106
                10.5152/TurkArchPediatr.2023.23157
                10837574
                37737227
                c1e42001-51e7-4361-9820-feb229953f1c
                2024 authors

                Content of this journal is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

                History
                : 14 July 2023
                : 8 August 2023
                Funding
                This study received no funding.
                Categories
                Diagnostic Challenge

                Comments

                Comment on this article